Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Abeona Therapeutics (ABEO) Return on Equity: 2011-2025

Historic Return on Equity for Abeona Therapeutics (ABEO) over the last 13 years, with Sep 2025 value amounting to -0.51%.

  • Abeona Therapeutics' Return on Equity rose 101.00% to -0.51% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.51%, marking a year-over-year increase of 101.00%. This contributed to the annual value of -2.32% for FY2024, which is 4.00% down from last year.
  • Latest data reveals that Abeona Therapeutics reported Return on Equity of -0.51% as of Q3 2025, which was up 34.77% from -0.79% recorded in Q2 2025.
  • Abeona Therapeutics' Return on Equity's 5-year high stood at -0.51% during Q3 2025, with a 5-year trough of -17.06% in Q1 2024.
  • In the last 3 years, Abeona Therapeutics' Return on Equity had a median value of -2.23% in 2024 and averaged -3.39%.
  • Per our database at Business Quant, Abeona Therapeutics' Return on Equity slumped by 1,517bps in 2024 and then spiked by 1,471bps in 2025.
  • Abeona Therapeutics' Return on Equity (Quarterly) stood at -1.53% in 2021, then slumped by 111bps to -2.64% in 2022, then rose by 6bps to -2.58% in 2023, then surged by 47bps to -2.11% in 2024, then skyrocketed by 101bps to -0.51% in 2025.
  • Its Return on Equity was -0.51% in Q3 2025, compared to -0.79% in Q2 2025 and -2.35% in Q1 2025.